by Five Rivers Rx | Aug 17, 2017 | Competition
America and Wall Street are a bit obsessed with Amazon; in fact, Amazon was named as a threat to 15% of S&P 500 earnings calls from Q2 2017. With that understanding, it is no surprise that the entire pharmaceutical supply chain shares similar fears. There is an...
by Five Rivers Rx | Aug 10, 2017 | Competition
The Big 3 have controlled over 90% of the wholesale drug market for over 10 years. At that size, they are close to a zero-sum game… there is no new business to win except from each other or through acquisitions that are limited on supply. PROFIT & SALES GROWTH...
by Five Rivers Rx | Aug 3, 2017 | Regulations
Gov. Jerry Brown has signed California Assembly Bill (AB) 602 into law, which will make it “unprofessional conduct for a licensee to acquire a nonprescription diabetes test device from…[any entity that is] not the nonprescription diabetes test device’s manufacturer or...
